To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Efficacy of polynucleotide solution vs hyaluronic acid for knee osteoarthritis

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2014

Efficacy of polynucleotide solution vs hyaluronic acid for knee osteoarthritis

Vol: 3| Issue: 8| Number:52| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

A randomized double-blind clinical trial on the treatment of knee osteoarthritis: the efficacy of polynucleotides compared to standard hyaluronian viscosupplementation

Knee. 2014 Jun;21(3):661-8

Contributing Authors:
LS Giarratana BM Marelli C Crapanzano SE De Martinis L Gala M Ferraro N Marelli W Albisetti

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

72 patients with knee osteoarthritis were randomized to intra-articular injections of either Condrotide or hyaluronic acid. Condrotide is a gel containing a solution of polynucleotides. The purpose of this study was to compare the efficacy of Condrotide to that of hyaluronic acid (HA), a standard injection therapy for knee osteoarthritis. Assessment of the KOOS and pain was performed at baseline, ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue